Owkin

Owkin

Owkin is the first end-to-end AI biotech on a mission to understand complex biology and ensure every patient gets the right treatment. We use cutting-edge causal AI to identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics. We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, immunity and inflammation. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research across seven cancer indications. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like F-Prime, GV and Bpifrance, among